BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37878066)

  • 1. The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT).
    Corbin LJ; Hughes DA; Bull CJ; Vincent EE; Smith ML; McConnachie A; Messow CM; Welsh P; Taylor R; Lean MEJ; Sattar N; Timpson NJ
    Diabetologia; 2024 Jan; 67(1):74-87. PubMed ID: 37878066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
    Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Stefanetti R; Trenell M; Welsh P; Kean S; Ford I; McConnachie A; Sattar N; Taylor R
    Lancet; 2018 Feb; 391(10120):541-551. PubMed ID: 29221645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
    Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R
    Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.
    Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Kelly T; Irvine K; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Adamson AJ; Sniehotta FF; Mathers JC; McIlvenna Y; Welsh P; McConnachie A; McIntosh A; Sattar N; Taylor R
    Lancet Diabetes Endocrinol; 2024 Apr; 12(4):233-246. PubMed ID: 38423026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
    Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
    Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes.
    Bull CJ; Hazelwood E; Legge DN; Corbin LJ; Richardson TG; Lee M; Yarmolinsky J; Smith-Byrne K; Hughes DA; Johansson M; Peters U; Berndt SI; Brenner H; Burnett-Hartman A; Cheng I; Kweon SS; Le Marchand L; Li L; Newcomb PA; Pearlman R; McConnachie A; Welsh P; Taylor R; Lean MEJ; Sattar N; Murphy N; Gunter MJ; Timpson NJ; Vincent EE
    EBioMedicine; 2024 Feb; 100():104977. PubMed ID: 38290287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
    Arora T; Velagapudi V; Pournaras DJ; Welbourn R; le Roux CW; Orešič M; Bäckhed F
    PLoS One; 2015; 10(5):e0126401. PubMed ID: 25946120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.
    Taylor R; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Sattar N; Welsh P; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Al-Mrabeh A; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Kean S; Ford I; McConnachie A; Lean MEJ
    Diabetologia; 2018 Mar; 61(3):589-598. PubMed ID: 29188339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolomic profiling identifies serum metabolites associated with type 2 diabetes in a cross-sectional study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Liu Y; Gan L; Zhao B; Yu K; Wang Y; Männistö S; Weinstein SJ; Huang J; Albanes D
    Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E167-E175. PubMed ID: 36516224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight management (GLoW) randomised controlled trial.
    Ahern AL; Woolston J; Wells E; Sharp SJ; Islam N; Lawlor ER; Duschinsky R; Hill AJ; Doble B; Wilson E; Morris S; Hughes CA; Brennan A; Bostock J; Boothby C; Griffin SJ
    BMJ Open; 2020 Apr; 10(4):e035020. PubMed ID: 32350016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
    Angelidi AM; Kokkinos A; Sanoudou D; Connelly MA; Alexandrou A; Mingrone G; Mantzoros CS
    Metabolism; 2023 Jan; 138():155346. PubMed ID: 36375643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Habitual physical activity and plasma metabolomic patterns distinguish individuals with low vs. high weight loss during controlled energy restriction.
    Piccolo BD; Keim NL; Fiehn O; Adams SH; Van Loan MD; Newman JW
    J Nutr; 2015 Apr; 145(4):681-90. PubMed ID: 25833772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.
    Churuangsuk C; Hall J; Reynolds A; Griffin SJ; Combet E; Lean MEJ
    Diabetologia; 2022 Jan; 65(1):14-36. PubMed ID: 34796367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
    Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.